Modern WisdomThe Ethics Of Using Drugs To Fall In & Out Of Love - Brian D. Earp | Modern Wisdom Podcast 268
CHAPTERS
- 0:00 – 1:00
A future of psychedelic-assisted couples therapy (and the authenticity question)
Brian opens by imagining near-future clinics offering psychedelic- or MDMA-enhanced couples therapy designed to break entrenched relationship patterns. He argues that temporarily shifting perception can help partners “see each other with new eyes” without making the resulting reconnection inherently inauthentic.
- 1:00 – 3:19
What love is: a bio-psycho-social phenomenon with stages
Chris asks “What is love?” and Brian builds an integrative view spanning subjective experience, cultural scripts, brain chemistry, and social context. He also discusses common phase models—lust, attraction, and attachment—each linked to different biological systems.
- 3:19 – 5:36
Reductionism vs lived experience: meaning, values, and “bad love”
They explore why love feels like more than chemicals, and how meaning and values get woven into romantic experience. Brian notes that some experiences people label ‘love’ may be obsessive or harmful, and societies can legitimately debate what counts as love.
- 5:36 – 7:19
Why we love who we love: proximity, compatibility, and unknown triggers
Chris asks what determines who we love; Brian emphasizes proximity and compatibility as strong predictors, while dismissing clichés like “absence makes the heart grow fonder.” Beyond broad factors, the specific spark remains scientifically elusive.
- 7:19 – 11:56
Where drugs fit in: mapping lust, attraction, and attachment onto neurochemistry
Brian outlines how drugs can interact with components of love: libido (testosterone), early-stage obsessive attraction (serotonin/OCD overlap), and attachment (oxytocin/vasopressin). He then pivots to psychedelics/MDMA as “global” state-shifters that may enhance therapy rather than directly create love.
- 11:56 – 13:45
Why psychedelic trials don’t fit the usual placebo model
They discuss the methodological challenge of studying psychedelics: participants can tell when they’ve taken the drug. Brian argues the subjective experience is not “noise” but often part of the mechanism of change, especially when integrated socially and therapeutically.
- 13:45 – 22:44
Anti-love drugs: when weakening attachment might be justified
Chris introduces ‘anti-love’ interventions; Brian starts with a hard case: abusive relationships where attachment can intensify despite harm. He then discusses voluntary use to align first-order feelings with higher-order goals, plus controversial cases like libido suppression for those attracted to children.
- 22:44 – 25:01
Pro-love drugs depend on context: SSRIs as relationship help or harm
Brian argues that “pro-love” vs “anti-love” is often context-dependent: the same drug can either support a relationship (by treating depression) or undermine it (through libido suppression or emotional blunting). The key variable is the interaction of drug effects with a couple’s values and situation.
- 25:01 – 25:59
Is Viagra a love drug? Indirect pathways through sex, bonding, and oxytocin
They examine whether erectile-dysfunction drugs count as “love drugs.” Brian suggests they can indirectly support intimacy and attachment if sexual connection is important to the couple, partly via increased sexual satisfaction and associated bonding mechanisms.
- 25:59 – 31:53
Could drugs change sexual orientation? Conversion therapy, autonomy, and coercion risks
Chris asks about orientation change; Brian recounts historical attempts to ‘convert’ gay people and modern cases where SSRIs are used to dampen libido in highly religious contexts. They explore the tension between respecting adult choice and recognizing non-ideal social pressures that could make such tech harmful.
- 31:53 – 45:23
How far should enhancement go? Bioconservatives vs bioliberals, nature, and unintended effects
They widen to human enhancement: tinkering with evolved systems is risky because we don’t fully understand them, yet refusing intervention ignores real suffering and potential benefits. Brian situates the debate between bioconservative caution and bioliberal/transhumanist optimism, noting both can be dogmatic.
- 45:23 – 52:28
Do drugs erase growth? Coping vs confronting emotions (SSRIs, MDMA for PTSD, and alcohol as analogy)
Chris worries about “nerfing” heartbreak and losing lessons; Brian distinguishes between drugs that paper over meaningful signals and drugs that help people access emotions safely. He uses SSRIs and MDMA-assisted psychotherapy for PTSD to show cases where medication can enable processing rather than avoidance.
- 52:28 – 1:04:49
Authenticity, the ‘true self,’ and relationship-enhancement criticisms
They tackle the core objection: drug-shaped feelings might be inauthentic. Brian introduces philosophical accounts of authenticity (e.g., willing vs unwilling addict) and shows how political/ideological values influence what we treat as someone’s ‘real self,’ especially in religion/sexuality conflicts.
- 1:04:49 – 1:12:11
Personal stance and a cautious path: last-resort, guided psychedelic couples therapy
Chris asks Brian’s personal position; Brian describes his conservative religious upbringing and current cautious openness. He outlines a ‘conservative’ framework: try non-drug methods first, then consider carefully structured, therapist-guided psychedelic work as one tool among many for breaking ruts and rebuilding habits.
- 1:12:11 – 1:15:03
Ancient roots of altered states and closing recommendations
They connect modern psychedelic therapy to older spiritual and cultural traditions that used psychoactive substances to dissolve ego and reset perception. The episode closes with Chris plugging Brian’s book and Brian sharing where to find his academic work online.
